Ariadna Recasens
John Hopkins Drive
Sydney, NSW 2006, Australia
Sydney, NSW 2006, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma.
Journal: Nature communications
Published: October 17, 2024
Barriers and hurdles delaying governance approval for an ethically approved nationwide clinical trial in pancreatic cancer.
Journal: ANZ journal of surgery
Published: March 22, 2024
DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells.
Journal: International journal of molecular sciences
Published: March 19, 2021
Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells.
Journal: Cell death discovery
Published: November 25, 2020
MerTK activity is not necessary for the proliferation of glioblastoma stem cells.
Journal: Biochemical pharmacology
Published: October 26, 2020
MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells.
Journal: Cancers
Published: February 10, 2020
Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting Agents.
Journal: ACS pharmacology & translational science
Published: July 03, 2019
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.
Journal: Acta neuropathologica communications
Published: January 24, 2018
In vivo models of alpha-synuclein transmission and propagation.
Journal: Cell and tissue research
Published: July 11, 2017
Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 06, 2017
Last Updated: 09/26/2026